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Abstract
Background: There is a lack of international research on suicide by drug overdose as a preventable suicide
method. Sex- and age-specific rates of suicide by drug self-poisoning (ICD-10, X60-64) and the distribution of drug
types used in 16 European countries were studied, and compared with other self-poisoning methods (X65-69) and
intentional self-injury (X70-84).
Methods: Data for 2000-04/05 were collected from national statistical offices. Age-adjusted suicide rates, and age
and sex distributions, were calculated.
Results: No pronounced sex differences in drug self-poisoning rates were found, either in the aggregate data
(males 1.6 and females 1.5 per 100,000) or within individual countries. Among the 16 countries, the range (from
some 0.3 in Portugal to 5.0 in Finland) was wide. ‘Other and unspecified drugs’ (X64) were recorded most
frequently, with a range of 0.2-1.9, and accounted for more than 70% of deaths by drug overdose in France,
Luxembourg, Portugal and Spain. Psychotropic drugs (X61) ranked second. The X63 category (’other drugs acting
on the autonomic nervous system’) was least frequently used. Finland showed low X64 and high X61 figures,
Scotland had high levels of X62 (’narcotics and hallucinogens, not elsewhere classified’) for both sexes, while
England exceeded other countries in category X60. Risk was highest among the middle-aged everywhere except in
Switzerland, where the elderly were most at risk.
Conclusions: Suicide by drug overdose is preventable. Intentional self-poisoning with drugs kills as many males as
females. The considerable differences in patterns of self-poisoning found in the various European countries are
relevant to national efforts to improve diagnostics of suicide and appropriate specific prevention. The fact that vast
majority of drug-overdose suicides came under the category X64 refers to the need of more detailed ICD coding
system for overdose suicides is needed to permit better design of suicide-prevention strategies at national level.
Background
Choice of suicide method is influenced by such factors
as availability of means, cultural acceptance, suicidal
intent and individual preference [1-3]. The methods
chosen have a major bearing on differential outcomes of
suicidal acts. Lethal methods (firearms, drowning and
hanging) predominantly characterise suicide while less
lethal ones (cutting and poisoning) are often used for
suicide attempts [1,4-6]. Females’ preferred method is
drug overdose, which is not usually lethal, whereas
males tend to prefer more lethal methods [2,5]. Methods
thus partially explain the sex paradox: although females
are more commonly diagnosed as depressed and their
suicide attempts are registered more frequently [6,7],
males’ suicide rates are considerably higher in most
countries [8].
Research into suicide methods has mostly explored
drug self-poisoning as one of several method categories
[1,9,10]. Use of specific drugs has prompted proposals
to restrict their availability [11-18]. Some studies have
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observed an association between rates of suicide and/or
attempted suicide and sale of specific medicines or
classes of drugs [14-16,19-21]. Studies exploring other
forms of self-poisoning, such as charcoal-burning [22]
and pesticide ingestion [23,24] focusing mainly on Asian
countries, have helped somewhat in formulation of med-
ical management guidelines. Comparative European
research on suicidal self-poisoning acts using drugs is
lacking.
Previous studies based on data from member coun-
tries in the ‘European Alliance Against Depression’
(EAAD) [25,26] have shown that self-poisoning is the
second or third most frequent suicide method for
females and males alike. It accounts for a quarter of all
female suicides overall and almost half of all female sui-
cides in some countries studied, including Finland, Ice-
land, England and Scotland [10].
Our study examined rates of sex- and age-specific self-
poisoning suicide (ICD-10, X60-64) and determined the
category composition of drugs used in 16 European coun-
tries. Comparisons were made with other means of self-
poisoning (X65-69) and intentional self-harm (X70-84).
Methods
Data collection
Data for 2000-04/2005 were collected from 16 member
countries in the EAAD project funded by the European
Commission. Since data on method-specific suicides are
not available from the WHO databank, male and female
suicide numbers in 10-year age groups and the respec-
tive population data were compiled from the partici-
pants’ national statistical offices. For the UK, English
and Scottish data were collected separately. Belgium is
represented by Flanders. A detailed description of the
data sources is given elsewhere [9,10].
Data based on the International Statistical Classifica-
tion of Diseases and Related Health Problems, Tenth
Revision (ICD-10, WHO 1992) were available from
Belgium, Estonia, Finland, France, Germany, Hungary,
Iceland, Luxembourg, the Netherlands, Portugal, Scot-
land, Slovenia, Spain and Switzerland. Self-poisoning
with drugs and other substances (codes X60-64 and
X65-69) and self-harm (X70-84) were analysed sepa-
rately. Fatal self-poisoning was identified using ICD-9
(WHO 1978), codes E950-E959, for England in 2000,
Portugal in 2000-01 and Ireland for the entire study per-
iod. Table 1 lists the five ICD-10 categories of inten-
tional self-poisoning with drugs. No category breakdown
was possible for Ireland because the relevant ICD-9 and
ICD-10 classifications were not comparable.
Data analysis
Annual age- and sex-specific suicide rates were calcu-
lated for the 16 countries individually and as a
combined EAAD dataset, with age-adjusted rates per
100,000 based on a European standard population [27].
To assess linear correlation (+1 to -1) between national
male and female rates of fatal, intentional drug overdose,
Pearson correlation coefficients were calculated.
Results
Overall, annual self-poisoning suicides averaged 2,511
for males and 2,580 for females in 2000-04/2005. As
Table 1 shows, the 16 countries’ data indicate that male
suicides are much more likely to be due to self-harm
(including hanging, drowning, shooting and jumping).
Male rates of self-poisoning not involving drugs also
exceeded female rates in all countries studied. Inten-
tional drug overdoses were almost equally frequent
among males and females: 1.6 and 1.5 respectively per
100,000 in the 16 countries combined. Finland had the
highest rates for both sexes.
The male-to-female ratio of suicide by drug self-poi-
soning in the aggregate data was 1.1, ranging from 0.8
(Estonia) to 1.4 (Iceland) in individual countries. For
other self-poisoning the aggregate male-to-female ratio
was 3.7, and for self-harm 3.9. Males’ and females’ drug-
overdose rates in the countries studied were strikingly
similar (r = 0.97). Rates of male and female self-injury
(r = 0.88) and self-poisoning not involving drugs (r =
0.67) also showed high positive correlation.
As Table 2 shows, for both sexes in the combined
data set, the vast majority of drug-overdose suicides
were registered as X64 (’Intentional self-poisoning by
and exposure to other and unspecified drugs, medica-
ments and biological substances’), followed by X61
(‘antiepileptic, sedative-hypnotic, antiparkinsonism and
psychotropic drugs, not elsewhere classified’). The X63
category (’other drugs acting on the autonomic nervous
system’) was least frequently used. Category proportions
of drugs used for overdose varied widely, but were
similar for both sexes in each country. In France,
Luxembourg, Portugal and Spain, X64 drugs accounted
for more than 70% of overdoses. Finland showed low
X64 and high X61 figures. Scotland had high levels of
X62 (‘narcotics and psychodysleptics [hallucinogens],
not elsewhere classified’) classification for both sexes,
while England exceeded other countries in category X60
(‘nonopioid analgesics, antipyretics and antirheumatics’).
The highest rates of drug self-poisoning suicide in the
combined dataset were found in males aged 35-54 and
females aged 45-54 (Table 3). The 15-24 age group had
the lowest rates for both sexes. For males, rates fell off
in the 55-64 age group but were slightly elevated among
those aged 65+. For females, rates in both the 55-64 and
the older (65+) age group were consistently lower.
Scotland had the highest drug-overdose suicide rates
in the 15-24 age group. Among people aged 25-34
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Table 1 Male and female age adjusted suicide rates per 100 000 and rate ratios, distributed by poisonings and
injuries in 16 European countries, means of the years 2000-2004/5
POISONINGS INJURIES TOTAL
Poisoning by drugs X60-X64 Other poisonings X65-X69 X60-X84
rate ratio M/F rate ratio M/F rate ratio M/F rate ratio M/F
Male Female Male Female Male Female Male Female
Belgium 1.8 1.6 1.1 1.0 0.3 3.3 22.6 7.2 3.2 25.3 9.1 2.8
England 1.3 1.0 1.3 1.1 0.1 8.6 6.8 1.4 4.7 9.2 2.6 3.6
Estonia 0.7 0.9 0.8 1.0 0.2 5.5 41.6 7.1 5.9 43.4 8.2 5.3
Finland 5.3 4.7 1.1 1.9 0.1 15.2 23.7 4.6 5.1 30.9 9.5 3.3
France 2.3 2.4 1.0 0.6 0.3 2.2 22.8 5.9 3.9 25.7 8.5 3.0
Germany 1.5 1.3 1.1 0.7 0.2 4.0 15.4 4.0 3.8 17.6 5.5 3.2
Hungary 3.0 2.9 1.1 2.3 0.7 3.2 39.0 7.2 5.4 44.2 10.7 4.1
Iceland 4.1 2.9 1.4 1.6 0.8 1.9 12.5 2.4 5.1 18.2 6.1 3.0
Ireland 1.6 1.3 1.2 0.6 0.1 9.6 18.0 3.4 5.2 20.2 4.8 4.2
Luxembourg 1.8 1.9 0.9 1.7 0.6 3.1 18.2 4.2 4.4 21.8 6.7 3.3
Netherlands 1.3 1.3 1.0 0.4 0.1 3.3 10.5 4.1 2.6 12.2 5.6 2.2
Portugal 0.3 0.3 0.9 1.8 0.8 2.3 11.3 2.4 4.8 13.3 3.4 3.9
Scotland 3.1 2.6 1.2 1.2 0.1 19.8 13.5 3.0 4.5 17.8 5.7 3.1
Slovenia 0.9 0.9 0.9 2.9 0.6 4.9 37.2 9.4 4.0 41.0 11.0 3.7
Spain 0.4 0.3 1.3 0.5 0.2 2.4 10.0 2.7 3.7 10.8 3.2 3.4
Switzerland 3.0 3.3 0.9 0.8 0.2 3.4 19.9 6.0 3.3 23.7 9.6 2.5
Total 1.6 1.5 1.1 0.8 0.2 3.6 15.6 4.0 3.9 18.0 5.7 3.2
X60 - nonopioid analgesics, antipyretics and antirheumatics.
X61 - antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified.
X62 - narcotics and psychodysleptics (hallucinogens), not elsewhere classified.
X63 - other drugs acting on the autonomic nervous system.
X64 - other and unspecified drugs, medicaments and biological substances.
Table 2 Percent distribution of drug poisoning suicides (X60-X64 by ICD-10) in 16 European countries by gender,
means of the years 2000-2004/5
X60 X61 X62 X63 X64 X60-64
Male Female Male Female Male Female Male Female Male Female Male Female
Belgium 0.0 0.0 30.9 35.8 9.1 3.8 0.0 0.0 60.0 60.4 100.0 100.0
England* 29.8 30.0 21.4 23.2 12.4 8.5 1.2 0.7 35.3 37.5 100.0 100.0
Estonia 0.0 0.0 50.0 42.9 0.0 0.0 0.0 14.3 50.0 42.9 100.0 100.0
Finland 4.2 4.5 72.7 67.9 10.5 10.4 4.9 6.7 7.7 10.4 100.0 100.0
France 0.6 0.4 17.4 17.0 1.5 1.1 1.0 1.1 79.5 80.5 100.0 100.0
Germany 1.1 1.3 24.3 26.8 9.7 3.6 1.4 1.5 63.5 66.8 100.0 100.0
Hungary 1.7 1.4 48.4 55.7 2.5 2.3 2.6 2.0 44.9 38.7 100.0 100.0
Iceland 3.4 5.3 48.3 73.7 0.0 0.0 0.0 5.3 48.3 15.8 100.0 100.0
Luxembourg 0.0 0.0 25.0 40.0 0.0 0.0 0.0 0.0 75.0 60.0 100.0 100.0
Netherlands 2.7 4.2 23.4 28.3 18.0 9.2 0.9 0.8 55.0 57.5 100.0 100.0
Portugal** 0.0 0.0 13.3 21.1 6.7 0.0 0.0 0.0 80.0 78.9 100.0 100.0
Scotland 12.8 14.3 33.3 35.7 43.6 38.6 1.3 2.9 9.0 8.6 100.0 100.0
Slovenia 0.0 0.0 33.3 54.5 33.3 18.2 0.0 0.0 33.3 27.3 100.0 100.0
Spain 0.0 1.5 17.4 22.4 7.0 3.0 1.2 0.0 74.4 73.1 100.0 100.0
Switzerland 0.8 0.6 70.2 77.1 4.1 3.8 5.8 0.0 19.0 18.5 100.0 100.0
Total 5.5 4.9 28.7 31.4 8.5 4.9 1.7 1.4 55.6 57.3 100.0 100.0
X60 - nonopioid analgesics, antipyretics and antirheumatics.
X61 - antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified.
X62 - narcotics and psychodysleptics (hallucinogens), not elsewhere classified.
X63 - other drugs acting on the autonomic nervous system.
X64 - other and unspecified drugs, medicaments and biological substances.
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Finland, Iceland and Scotland had the highest rates. For
the 65+ age group, remarkably high rates of suicide by
drug self-poisoning were found in Switzerland (females
12.31, males 12.25 per 100,000) and the lowest for
females in Spain (0.2/100,000) and males in Estonia
(0.2/100.000) (Table 3).
Discussion
This study focused on drug-overdose suicides (ICD-10,
X60-64) in recent years, comparing their prevalence and
effects of sex and age in the 16 member countries of the
European Commission’s ‘European Alliance Against
Depression’ (EAAD) project.
Sex and country differences
Sex is clearly a major demographic factor in choice of
suicide methods [1,10,28]. The recent EAAD study
showed that more than a quarter of female suicides
involved intentional self-poisoning with drugs, while for
males drug self-poisoning accounted for less than 10%
[9]. Several factors explain why females ingest drugs for
suicidal purposes relatively often. Townsend [15] sug-
gested that females’ weaker intention to die may contri-
bute to their high rates of drug overdose. Lester [6]
associated the female preference for drug use in suicidal
acts with greater concern for bodily appearance after
death, and painlessness as one reason for this prefer-
ence. Shapira [12] stressed males’ greater propensity to
violence. Regarding availability of means, Moller-Leim-
kuhler [28] cited the association between females’
greater propensity to major depression and availability
of prescription drugs, while linking males’ higher suicide
rate with their more frequent gun ownership.
Despite the sexes’ different rates of drug overdose, the
present study highlights the similarity of drug self-
poisoning rates in most countries and in the aggregate
data (1.6 and 1.5 respectively). This similarity is
independent of the countries’ overall suicide rates and
male-to-female ratios. Males’ far higher overall suicide
rates are due to injury deaths, which were nearly four
times higher than in females, while for drug overdoses
the male-to-female ratio was very close to 1.
For parasuicide, unlike completed suicide, drug self-
poisoning is a high-ranking method for both sexes, indi-
cating its low lethality. The WHO/EURO Multicentre
Study on Parasuicide reported that in 14 European
countries, 73% of male and 84% of female suicide
attempts were due to drug overdoses [5]. The conclu-
sion was that, in the context of overall suicidality, drugs
warrant great attention as means. The relatively rarity of
fatal outcomes may be due to effective toxicological aid;
thus, many suicide attempters using drugs survive and
are excluded from suicide statistics. Nevertheless, the
WHO/EURO study showed striking differences in drug-
overdose rates between countries. This is consistent
with the present study’s findings on completed suicides.
The country comparisons showed striking variations
in sex rates, with implications for preventive policies. In
Finland, rates of intentional drug-overdose death are
particularly high for both sexes; drug overdoses cause
half of the female suicides. Iceland, Scotland, Hungary
and Switzerland are other high-risk countries in terms
Table 3 Male and female suicide rates per 100 000, poisoning by drugs (X60-X64 by ICD 10) by age groups in 16
European countries, means of 2000-2004/5
Males Females
15-24 25-34 35-44 45-54 55-64 65+ 15-24 25-34 35-44 45-54 55-64 65+
Belgium 1.2 2.5 3.1 3.3 1.9 1.3 Belgium 0.7 1.2 3.2 3.6 2.4 1.3
England 0.5 1.9 2.3 2.3 1.4 1.9 England 0.5 1.1 1.3 1.6 1.6 2.0
Estonia 1.0 0.5 0.9 0.8 1.5 0.2 Estonia 1.2 2.0 0.7 1.0 1.4 0.5
Finland 2.1 7.1 10.8 10.6 5.5 3.8 Finland 2.3 4.3 7.9 9.8 7.9 4.0
France 0.7 3.0 5.0 4.5 2.4 1.7 France 0.7 1.9 4.2 5.1 3.8 2.4
Germany 0.6 1.8 2.4 2.4 2.1 2.1 Germany 0.6 1.0 1.7 2.2 2.3 2.7
Hungary 0.9 2.4 5.3 5.6 3.7 5.9 Hungary 0.6 1.3 3.7 5.5 4.1 7.5
Iceland 1.7 7.3 6.7 8.4 3.1 3.6 Iceland 0.0 2.7 2.9 7.8 6.7 2.4
Ireland 1.1 2.9 2.8 2.4 2.1 1.1 Ireland 1.6 1.0 2.4 2.1 1.7 1.3
Luxembourg 0.6 2.0 3.0 3.7 0.7 3.9 Luxembourg 0.0 0.5 1.8 5.5 4.4 3.1
Netherlands 0.4 1.5 2.1 2.3 1.9 2.0 Netherlands 0.2 0.9 2.0 2.9 2.3 2.1
Portugal 0.2 0.3 0.5 0.5 0.5 0.4 Portugal 0.0 0.3 0.6 0.5 0.6 0.5
Scotland 2.6 5.2 6.0 4.3 2.8 2.1 Scotland 2.7 3.2 4.3 4.7 2.7 1.8
Slovenia 0.8 2.1 1.1 1.2 0.4 0.7 Slovenia 1.0 0.4 1.8 1.2 1.5 1.4
Spain 0.1 0.6 0.8 0.5 0.4 0.3 Spain 0.1 0.3 0.5 0.6 0.4 0.2
Switzerland 0.7 1.7 2.7 3.3 4.3 12.3 Switzerland 1.0 1.6 2.5 3.7 6.4 12.3
Total 0.6 1.9 2.8 2.8 1.9 2.0 Total 0.6 1.2 2.2 2.9 2.4 2.4
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of both sexes’ overdose rates, perhaps reflecting the
availability of certain drugs, such as antidepressants and
psychotropics [29]. Improving depression treatment may
lower suicide rates, but prescription drugs can be used
for suicidal purposes. More attention should therefore
be paid to preventive measures in medical management.
Subcategories of drugs involved in self-poisoning
Combined data from the countries studied show that, in
more than half the cases of male and female suicide by
overdose, drugs from the X64 category predominate.
Since this category includes ‘other and unspecified
drugs’, data recording is likely to be poor. It may be sus-
pected that doctors issuing death certificates are unwill-
ing to work on detecting drugs taken by the deceased
or, in the event of multiple drug use, whether an X64
drug was included. Overall, this category needs refining
in terms of, for example, drug combinations, unidenti-
fied drugs and biological substances.
Efforts should be made to improve recording systems
and investigation procedures, especially in France,
Luxembourg, Portugal and Spain, where category X64
drugs are implicated in more than 70% of overdose sui-
cides. The small proportions of X64 drugs in Finland
and Scotland reflect careful diagnostics of drugs used
for overdoses.
The second most prevalent drug category, X61, is also
heterogeneous. Antiepileptic, sedative-hypnotic, anti-
parkinsonism and psychotropic drugs are prescribed by
different specialists, making it difficult to develop speci-
fic strategies to prevent these suicides by systematically
limiting access to these medicines. The greatest poten-
tial for prevention may be predicted in Finland and
Switzerland.
Previous studies, reporting on sex differences in sui-
cide by drug overdose in such countries as Denmark,
England and Australia [11,12,21,30,31], suggested that
drugs in categories X61 and X60 (non-opioid analgesics
etc) predominate as means of suicide. The results of the
present study show also that X60 drugs are the most
frequently ingested in fatal overdoses in Scotland and
England [30], and a much higher rate of self-poisoning
with analgesics is reported in the UK than elsewhere in
Europe [3,14].
Scotland and Finland, on the other hand, show high
rates of suicide using narcotics (X62). Interpretation is
difficult; whether these cases are related to drug addicts’
deaths not listed as suicides in other countries is
unknown. Drug suicide may be difficult to distinguish
from accidental death by overdose.
A comparison of the present study’s findings with
those of the WHO/Euro Multicentre Parasuicide Study
[5] shows country-specific similarities in the drugs cho-
sen. For attempted and completed suicides alike,
overdose rates for some drugs, such as analgesics (X60)
in England and Scotland, and psychotropic drugs (X61)
in Finland, are high.
Age-specific drug overdose
The overall age distribution of suicide rates is not uni-
form. They peak around age 50 in males and 60 in
females. Countries differ, but within each country male
and female patterns are highly similar. In Finland and
Scotland, high youth suicide rates cause concern [28,32].
Several drug-related studies, subject to limitations of
geographical area and size, have highlighted the fre-
quency of drug overdose in the elderly. Since drug over-
dose is the predominant suicide method among people
aged 60 and over, careful prescription is imperative in
this age group [2,33].
This study found exceptionally high rates of suicide by
drug self-poisoning among the over-65s of both sexes in
Switzerland [34]. This partially reflects assisted suicides
among the elderly there, and may indicate a need to
review the legal basis for assisted suicide, currently
offered by two private organisations (EXIT and DIGNI-
TAS) [35]. However, the present study also indicates
that both Switzerland and Hungary need to improve sui-
cide prevention among the elderly, perhaps through
efforts to enhance their quality of life.
Prevention
Compared with highly lethal methods, prevention of
drug-related suicide across the lifespan has attracted lit-
tle attention [2], because using drugs is among the least
lethal methods [4,10]. Intentional drug overdose, widely
used by suicidal individuals, is relatively non-lethal
partly because of its distinctive delay between initiation
of the suicidal act and death. This delay offers ample
scope for prevention: better potential for detection and
intervention, and anticipated advances in medical toxi-
cology. Success in these endeavours could turn poten-
tially fatal suicides into suicide attempts. Preventive
measures, being far more cost-effective, should nonethe-
less be given priority.
The number of intentional lethal self-poisoning acts
may be underestimated because a sizeable proportion of
those who commit them reach hospital alive, but then
die from complications. These deaths are not reported
as suicides in mortality statistics. The long-term impact
of chronic liver damage from paracetamol poisoning is
also worth mentioning [14,16,18]. A further factor con-
tributing to underestimation may be that since death by
poisoning lacks a dramatic visible outcome (unlike
hanging or firearm use), families can conceal the real
cause of death.
Preventing drug use in suicidal acts involves careful
and appropriate prescription, particularly to treat mental
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illnesses. This can be achieved through training of GPs,
other physicians and pharmacists [36,37]. Overdose
safety should be a key criterion for selecting drugs for
psychiatric treatment, for example choosing between tri-
cyclic antidepressants and newer, safer antidepressants
such as selective serotonin reuptake inhibitors (SSRIs)
[38].
Key strategies to reduce self-harm from intentional
drug overdose include a public-health approach: inform-
ing patients and their families about the dangers of
medicines; controlling their availability; and making it
easier to dispose of unused tablets [37]. Governments
and agencies should be obliged to regulate access to
lethal substances, promote training programmes and
define international standards. Future development
should be based on other countries’ best practices, espe-
cially those incorporating effective monitoring and
evaluation strategies [39]. One such practice may be the
‘e-clinic’ system being introduced in Estonia, enabling
all physicians to share information about their patients’
state of health and coordinate prescriptions. However,
the e-clinic approach presents real ethical problems
regarding extended access to sensitive data.
Contrary to the ‘method substitution hypothesis’,
which suggests that restricting access to some means of
suicide results in substitution of alternative methods,
numerous studies have demonstrated that such restric-
tions can reduce the number of completed suicides
[36,37,39,40]. Mortality from drug self-poisoning has
decreased because of measures to make barbiturates less
readily available in Australia [20], England and Wales
[12], reduce the size of analgesic packs sold over the
counter in the UK [13], improve safety in therapy with
psychotropic drugs in Hungary [29], prescribe less toxic
medication and smaller amounts of toxic drugs in
Denmark [11], and withdraw co-proxamol in Scotland
[18]. Mann et al. [36] found that for common methods,
restricting means has reduced overall suicide rates, but
that it does not entirely discount the method-substitu-
tion theory.
Study strengths and limitations
To our knowledge this is the first time that compara-
tive international data on intentional drug overdose
have been analysed in separate categories. The data are
not publicly available and were collected separately by
each country’s project participants. They permitted
comparison of the countries by sex, age and categories
of drugs used for intentional overdose, and reveal that
drug ingestion also causes male suicides. The data
could be used to improve suicide diagnostics and sui-
cide prevention programmes. The study revealed also
the need to redefine the ICD-10 X60-64 codes in more
detail.
This study’s limitations include its ecological design
and aggregate data level, which rule out detailed investi-
gation of the various drug categories, such as drug
names or doses taken in overdoses. The ICD-10 X60-64
codes are clearly an inadequate classification for detailed
use and lethality detection. Designing prevention pro-
grammes calls for a refined coding system. Further
research must focus on specific drugs in national
samples.
The study years chosen, 2000-04/05, imposed another
limitation. Since the ICD-9 and ICD-10 classifications
are not comparable, Ireland – where ICD-9 was used
throughout the study period – is excluded from the
category breakdown of overdose drugs presented in
Table 2. England was included after ICD-10 superseded
ICD-9 in 2001, and Portugal after its mortality registra-
tion system was restructured in 2002.
Conclusions
Both sexes use drug self-poisoning, a preventable suicide
method, equally. Overdose patterns vary widely among
the countries, but within them no substantial divergence
in sex and age patterns in drug choice are found. The
comparative data are relevant for improving suicide
registration, designing suicide prevention strategies at
national or regional level and learning best practices of
drug management in countries where drug overdose is
relatively unusual. These data show that drug self-
poisoning merits attention from clinical and public-
health viewpoints. This requires a more detailed ICD
coding system for overdose suicides.
Acknowledgements
We wish to thank, for their assistance in data collection, Esä Aromaa (South
Ostrobothnia Hospital District, Finland), Jean-Hervé Bouleau (Fédération de
Psychiatrie, France), Högni Oskarsson (Directorate of Health, Iceland), Ann
Palmer (University of Kent, UK), Victor Pérez Sola (Hospital de la Santa Creu i
Sant Pau, Spain) and Charles Pull (Centre Hospitalier de Luxembourg,
Luxembourg). Thanks are due to Clare James for her thorough linguistic and
stylistic revision of the manuscript.
The research received funding from the European Community’s Seventh
Framework Programme (FP7/2007-2013) under grant agreement No. 223138,
and from the Estonian Ministry of Social Affairs.
Author details
1Estonian-Swedish Mental Health and Suicidology Institute; Estonian Centre
of Behavioural and Health Sciences, Õie 39, Tallinn, 11615, Estonia. 2Institute
of Social Work, Tallinn University, Narva mnt 25, Tallinn, 10120, Estonia. 3The
Estonian Institute for Population Studies, Tallinn University, Narva mnt 25,
Tallinn, 10120, Estonia. 4National Suicide Research Foundation, 1 Perrott
Avenue, College Road, Cork, Ireland. 5Department of Nursing and Midwifery,
University of Stirling, FK9 4LA, Stirling, Great Britain. 6Department of
Psychiatry, University Hospital of Psychiatry, Bolligenstr.111, 3000 Bern 60,
Switzerland. 7De partamento de Saúde Mental, Faculdade de Ciências
Médicas, FCM, Universidade Nova de Lisboa, Campo dos Mártires da Pátria
130, 1169-056 Lisboa, Portugal. 8Katholieke Universiteit Leuven, LUCAS,
Kapucijnenvoer 39 - bus 5310, 3000 Leuven, Belgium. 9Trimbos-instituut/
Netherlands Institute of Mental Health and Addiction, Da Costakade 45, 3521
VS Utrecht, The Netherlands. 10Institute of Behavioural Sciences, Semmelweis
University, Nagyvárad tér 4, 1089 Budapest, Hungary. 11Inštitut za varovanje
Värnik et al. BMC Public Health 2011, 11:61
http://www.biomedcentral.com/1471-2458/11/61
Page 6 of 8
zdravja RS Insititute of Public Health of the Republic of Slovenia, Trubarjeva,
1000 Ljubljana, Slovenia. 12Department of Psychiatry, University of Leipzig,
Semmelweisstr.10, 04103 Leipzig, Germany.
Authors’ contributions
AV participated in developing the study conception and design, data
analysis and interpretation, drafting the article, revising it critically for
important intellectual content and final approval of the version to be
published. MS, PV, JW and KK participated in data analysis and interpretation,
drafting the article, revising it critically for important intellectual content and
final approval of the version to be published. EA, MM, TR, RG, CA, GS, CF-C,
CC, MK, AS and SR participated in data analysis and interpretation, revising
the article critically for important intellectual content and final approval of
the version to be published. UH participated in developing the study
conception and design, data analysis and interpretation, revising the article
critically for important intellectual content and final approval of the version
to be published.
Competing interests
The authors declare that they have no competing interests.
Received: 19 October 2010 Accepted: 29 January 2011
Published: 29 January 2011
References
1. Denning DG, Conwell Y, King D, Cox C: Method choice, intent, and
gender in completed suicide. Suicide Life Threat Behav 2000, 30(3):282-288.
2. Gunnell D, Ho D, Murray V: Medical management of deliberate drug
overdose: a neglected area for suicide prevention? Emerg Med J 2004,
21(1):35-38.
3. Ajdacic-Gross V, Weiss MG, Ring M, Hepp U, Bopp M, Gutzwiller F,
Rossler W: Methods of suicide: international suicide patterns derived
from the WHO mortality database. Bull World Health Organ 2008,
86(9):726-732.
4. Spicer RS, Miller TR: Suicide acts in 8 states: incidence and case fatality
rates by demographics and method. Am J Public Health 2000,
90(12):1885-1891.
5. Michel K, Ballinari P, Bille-Brahe U, Bjerke T, Crepet P, De Leo D, Haring C,
Hawton K, Kerkhof A, Lonnqvist J, Querejeta I, Salander-Renberg E,
Schmidtke A, Temesvary B, Wasserman D: Methods used for parasuicide:
results of the WHO/EURO Multicentre Study on Parasuicide. Soc
Psychiatry Psychiatr Epidemiol 2000, 35(4):156-163.
6. Lester D: Why do people choose particular methods for suicide. Act Nerv
Super 1988, 30:312-314.
7. Canetto SS, Sakinofsky I: The gender paradox in suicide. Suicide Life Threat
Behav 1998, 28(1):1-23.
8. Bertolote JM, Fleischman A: A global perspective on the magnitude of
suicide mortality. In Oxford Textbook of Suicidology and Suicide Prevention.
Edited by: Wasserman D, Wasserman C. Oxford: Oxford University Press;
2009:91-98.
9. Varnik A, Kolves K, Allik J, Arensman E, Aromaa E, van Audenhove C,
Bouleau JH, van der Feltz-Cornelis CM, Giupponi G, Gusmao R, Kopp M,
Marusic A, Maxwell M, Oskarsson H, Palmer A, Pull C, Realo A, Reisch T,
Schmidtke A, Perez Sola V, Wittenburg L, Hegerl U: Gender issues in
suicide rates, trends and methods among youths aged 15-24 in 15
European countries. J Affect Disord 2009, 113(3):216-226.
10. Varnik A, Kolves K, van der Feltz-Cornelis CM, Marusic A, Oskarsson H,
Palmer A, Reisch T, Scheerder G, Arensman E, Aromaa E, Giupponi G,
Gusmao R, Maxwell M, Pull C, Szekely A, Sola VP, Hegerl U: Suicide
methods in Europe: a gender-specific analysis of countries participating
in the “European Alliance Against Depression”. J Epidemiol Community
Health 2008, 62(6):545-551.
11. Nordentoft M, Qin P, Helweg-Larsen K, Juel K: Restrictions in means for
suicide: an effective tool in preventing suicide: the Danish experience.
Suicide Life Threat Behav 2007, 37(6):688-697.
12. Schapira K, Linsley KR, Linsley A, Kelly TP, Kay DW: Relationship of suicide
rates to social factors and availability of lethal methods: comparison of
suicide in Newcastle upon Tyne 1961-1965 and 1985-1994. Br J Psychiatry
2001, 178:458-464.
13. Hawton K, Simkin S, Deeks J, Cooper J, Johnston A, Waters K, Arundel M,
Bernal W, Gunson B, Hudson M, Suri D, Simpson K: UK legislation on
analgesic packs: before and after study of long term effect on
poisonings. BMJ 2004, 329(7474):1076.
14. Hawton K, Simkin S, Gunnell D, Sutton L, Bennewith O, Turnbull P, Kapur N:
A multicentre study of coproxamol poisoning suicides based on
coroners’ records in England. Br J Clin Pharmacol 2005, 59(2):207-212.
15. Townsend E, Hawton K, Harriss L, Bale E, Bond A: Substances used in
deliberate self-poisoning 1985-1997: trends and associations with age,
gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol
2001, 36(5):228-234.
16. Gunnell D, Hawton K, Murray V, Garnier R, Bismuth C, Fagg J, Simkin S: Use
of paracetamol for suicide and non-fatal poisoning in the UK and
France: are restrictions on availability justified? J Epidemiol Community
Health 1997, 51(2):175-179.
17. Cheeta S, Schifano F, Oyefeso A, Webb L, Ghodse AH: Antidepressant-
related deaths and antidepressant prescriptions in England and Wales,
1998-2000. Br J Psychiatry 2004, 184:41-47.
18. Sandilands EA, Bateman DN: Co-proxamol withdrawal has reduced suicide
from drugs in Scotland. Br J Clin Pharmacol 2008, 66(2):290-293.
19. Lester D, Abe K: The effect of controls on sedatives and hypnotics and
their use for suicide. J Toxicol Clin Toxicol 1989, 27(4-5):299-303.
20. Oliver RG, Hetzel BS: Rise and fall of suicide rates in Australia: relation to
sedative availability. Med J Aust 1972, 2(17):919-923.
21. Shah R, Uren Z, Baker A, Majeed A: Trends in suicide from drug overdose
in the elderly in England and Wales, 1993-1999. Int J Geriatr Psychiatry
2002, 17(5):416-421.
22. Chan KP, Yip PS, Au J, Lee DT: Charcoal-burning suicide in post-transition
Hong Kong. Br J Psychiatry 2005, 186:67-73.
23. Bertolote JM, Fleischmann A, Butchart A, Besbelli N: Suicide, suicide
attempts and pesticides: a major hidden public health problem. Bull
World Health Organ 2006, 84(4):260.
24. Roberts DM, Karunarathna A, Buckley NA, Manuweera G, Sheriff MH,
Eddleston M: Influence of pesticide regulation on acute poisoning
deaths in Sri Lanka. Bull World Health Organ 2003, 81(11):789-798.
25. Hegerl U, Wittmann M, Arensman E, Van Audenhove C, Bouleau JH, Van
Der Feltz-Cornelis C, Gusmao R, Kopp M, Lohr C, Maxwell M, Meise U,
Mirjanic M, Oskarsson H, Sola VP, Pull C, Pycha R, Ricka R, Tuulari J, Varnik A,
Pfeiffer-Gerschel T: The ‘European Alliance Against Depression (EAAD)’: a
multifaceted, community-based action programme against depression
and suicidality. World J Biol Psychiatry 2008, 9(1):51-58.
26. Hegerl U, Wittenburg L: Focus on mental health care reforms in
Europe: the European alliance against depression: a multilevel
approach to the prevention of suicidal behavior. Psychiatr Serv 2009,
60(5):596-599.
27. Cancer Incidence in Five Continents, Vol III. In IARC Scientific Publications
No 15. Edited by: Waterhouse J, Muir C, Correa P, Powell J. Lyon: IARC;
1976:456.
28. Moller-Leimkuhler AM: The gender gap in suicide and premature death
or: why are men so vulnerable? Eur Arch Psychiatry Clin Neurosci 2003,
253(1):1-8.
29. Rihmer Z, Belso N, Kalmar S: Antidepressants and suicide prevention in
Hungary. Acta Psychiatr Scand 2001, 103(3):238-239.
30. Kapur N, Turnbull P, Hawton K, Simkin S, Sutton L, Mackway-Jones K,
Bennewith O, Gunnell D: Self-poisoning suicides in England: a
multicentre study. Q J Med 2005, 98(8):589-597.
31. Oei TP, Foong T, Casey LM: Number and type of substances in alcohol
and drug-related completed suicides in an Australian sample. Crisis 2006,
27(2):72-76.
32. Buckley NA, Dawson AH, Whyte IM, Hazell P, Meza A, Britt H: An analysis of
age and gender influences on the relative risk for suicide and
psychotropic drug self-poisoning. Acta Psychiatr Scand 1996,
93(3):168-171.
33. Cattell H, Jolley DJ: One hundred cases of suicide in elderly people. Br J
Psychiatry 1995, 166(4):451-457.
34. Avery D: Assisted suicide seekers turn to Switzerland. Bull World Health
Organ 2003, 81(4):310.
35. Fischer S, Huber CA, Imhof L, Mahrer Imhof R, Furter M, Ziegler SJ,
Bosshard G: Suicide assisted by two Swiss right-to-die organisations. J
Med Ethics 2008, 34(11):810-814.
36. Mann JJ, Apter A, Bertolote J, Beautrais A, Currier D, Haas A, Hegerl U,
Lonnqvist J, Malone K, Marusic A, Mehlum L, Patton G, Phillips M, Rutz W,
Rihmer Z, Schmidtke A, Shaffer D, Silverman M, Takahashi Y, Varnik A,
Värnik et al. BMC Public Health 2011, 11:61
http://www.biomedcentral.com/1471-2458/11/61
Page 7 of 8
Wasserman D, Yip P, Hendin H: Suicide prevention strategies: a
systematic review. JAMA 2005, 294(16):2064-2074.
37. Leenaars A, Lester D, Baquedano G, Cantor C, Connolly JF, Ovuga E,
Remigio SP, Vijayakumar L: Restriction of access to drugs and medications
in suicide prevention. In Oxford Textbook of Suicidology and Suicide
Prevention. Edited by: Wasserman D, Wasserman C. Oxford: Oxford
University Press; 2009:573-576.
38. Bramness JG, Walby FA, Tverdal A: The sales of antidepressants and
suicide rates in Norway and its counties 1980-2004. J Affect Disord 2007,
102(1-3):1-9.
39. Taylor SJ, Kingdom D, Jenkins R: How are nations trying to prevent
suicide? An analysis of national suicide prevention strategies. Acta
Psychiatr Scand 1997, 95(6):457-463.
40. Daigle MS: Suicide prevention through means restriction: assessing the
risk of substitution. A critical review and synthesis. Accid Anal Prev 2005,
37(4):625-632.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2458/11/61/prepub
doi:10.1186/1471-2458-11-61
Cite this article as: Värnik et al.: Drug suicide: a sex-equal cause of
death in 16 European countries. BMC Public Health 2011 11:61.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Värnik et al. BMC Public Health 2011, 11:61
http://www.biomedcentral.com/1471-2458/11/61
Page 8 of 8
